Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.
Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores
Jacob M Jenssen
During the pandemic emergency in 2020, favipiravir, a pyrazine analog, is proposed as a providential antiviral agent against the COVID-19 infection. Fabric phase sorptive extraction (FPSE) and gas chromatography-mass spectrometry (GC-MS) have been developed and used for the first time to identify favipiravir (FAV) in pharmaceutical, forensic, and biological samples (human plasma, blood, and urine). FAV is extracted using FPSE, its derivatization using N, O-bis (trimethylsilyl) trifluoroacetamide (BSTFA), and GC-MS analysis are all part of the procedure. Placket-Burman Design (PBD) and Central Composite Design (CCD) were utilized for the screening of FPSE’s significant factors and their optimization, respectively, in the design of experiment-based optimization. For FAV, solgel polyethylene glycol (PEG) provided the highest extraction efficiency of all tested membranes. By GC-MS, the proposed method was found to be linear between 0.01 and 10 g mL-1 under ideal conditions. By GC-MS, the LODs and LOQs were as low as 0.001-0.0026 g mL1 and 0.003-0.0086 g mL1. Intra-day and between day precisions were under 5 and 10%, individually, showing great strategy accuracy.